Lungs News and Research

RSS

Evidence that Long COVID-19 impacts children

The ongoing coronavirus 2019 (COVID-19) pandemic has caused over one hundred million reported infections, with over 2.23 million deaths worldwide. While most cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection are asymptomatic or mild, some patients report long-haul symptoms, often severely debilitating in nature. However, it is unclear how many children are affected similarly.

2 Feb 2021

Researchers investigate ski resorts to assess risk of COVID-19 infection

Where do the greatest risks of infection lurk? How can you protect yourself and others even better? Scientists all over the world are working to expand knowledge about Covid-19 – including at Empa.

2 Feb 2021

Inhaling unfragmented hyaluronan improves lung function in COPD patients

Researchers at the National Institutes of Health and their collaborators found that inhaling unfragmented hyaluronan improves lung function in patients suffering from severe exacerbation of chronic obstructive pulmonary disease (COPD).

1 Feb 2021

Inhaled single dose vaccine creates antibodies and prevents infection in rhesus macaques

Now, a new preprint research paper describes a chimpanzee adenovirus-vectored vaccine that, when administered intranasally in rhesus macaques, led to a robust immune response and demonstrated protection against infection by the virus that causes COVID-19, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The preprint is published on the bioRxiv server.

1 Feb 2021

SARS-CoV-2-specific T cells are key players in decreasing COVID-19 mortality

A recent US study, currently available on medRxiv preprint server, supports a beneficial rather than immunopathologic role for effector T-cells during serious infections with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) –

31 Jan 2021

Study finds surprising defensive functions of the immune system against new viral attacks

Scientists are opening new windows into understanding more about the constantly shifting evolutionary arms race between viruses and the hosts they seek to infect.

29 Jan 2021

New machine learning model predicts COVID-19 severity

COVID-19 vaccine distribution has begun across the globe, while many countries are still struggling with the rampant rise of infections.

28 Jan 2021

Fetal and neonatal therapy combination may lessen the aftereffects of congenital CMV infection

A cross-institutional research group has revealed for the first time in the world that infants with symptomatic congenital cytomegalovirus (CMV) infection who were treated with a combination of immunoglobulin fetal therapy and neonatal therapy with antiviral drugs were less likely to experience the severe aftereffects associated with the infection than those who only received the neonatal therapy.

28 Jan 2021

SARS-CoV-2 is resistant to extreme variations in temperature, finds study

A recent study from Belize and Taiwan shows that four essential proteins of SARS-CoV-2 are well adapted to habitable temperatures and exhibit extreme thermostability, which means temperature changes between the winter and summer months have a negligible effect on the viral spread.

28 Jan 2021

New covid cases plunge 25% or more as behavior changes

A dozen states are reporting drops of 25% or more in new covid-19 cases and more than 1,200 counties have seen the same, federal data released Wednesday shows. Experts say the plunge may relate to growing fear of the virus after it reached record-high levels, as well as soaring hopes of getting vaccinated soon.

28 Jan 2021

Common anticoagulant drug could be repurposed to help alleviate Covid-19 infections

An international team of researchers led by the Universities of Keele and Liverpool, working with Public Health England, has found that the common anticoagulant drug heparin inhibits the SARS-Cov2virus spike protein, by reducing the virus' ability to attach to human cells and infect them.

28 Jan 2021

Moderna vaccine shows robust suppression of SARS-CoV-2 infection in animal model

Researchers have demonstrated that the prime or prime-boost vaccination of Moderna vaccine in hamsters induced robust neutralizing antibodies, ameliorated weight loss, and suppressed SARS-CoV-2 replication in the airways.

28 Jan 2021

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2, preventing expression of genes that encode proteins in cells such as resident macrophages in the nose and pulmonary alveoli, and epithelial cells lining the alveoli, all of which are entry points for the virus.

28 Jan 2021

Vaccines delivered via skin may offer better protection against respiratory diseases

Among infectious diseases that have caused pandemics and epidemics, smallpox stands out as a success story. Smallpox vaccination led to the disease's eradication in the twentieth century.

27 Jan 2021

New model could help clinicians to safely allow two patients to share a single ventilator

As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.

27 Jan 2021

Study shows several peridomestic mammal species are potential spreaders of SARS-CoV-2

Researchers from the US and Australia show that several common peridomestic species (including deer mice, striped skunks and bushy-tailed woodrats) are amenable to infection with SARS-CoV-2.

26 Jan 2021

Bispecific antibody shows efficacy against new SARS-CoV-2 variants

A team of international scientists has recently developed a bispecific antibody that can bind two non-overlapping regions of the spike receptor-binding domain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and completely prevent the viral-host interaction.

25 Jan 2021

Promising nanobodies against COVID-19 produced by llamas

News-Medical speaks to Dr. David Brody about his latest research that involved discovering nanobodies produced by llamas that could help combat coronavirus.

25 Jan 2021

Second-generation double antibody protects from SARS-CoV-2 and its tested variants

The Institute for Research in Biomedicine (IRB; Bellinzona, Switzerland), affiliated to the Università della Svizzera italiana (USI) developed a second-generation 'double antibody' that protects from SARS-CoV-2, the virus causing COVID-19, and all its tested variants. It also prevents the virus from mutating to resist the therapy.

24 Jan 2021

Does hypertension always lead to severe COVID-19?

Researchers have developed some prognostic factors to predict the severity of COVID-19 among hypertensive patients.

22 Jan 2021

Lungs News and Research

Evidence that Long COVID-19 impacts children

Researchers investigate ski resorts to assess risk of COVID-19 infection

Inhaling unfragmented hyaluronan improves lung function in COPD patients

Inhaled single dose vaccine creates antibodies and prevents infection in rhesus macaques

SARS-CoV-2-specific T cells are key players in decreasing COVID-19 mortality

Study finds surprising defensive functions of the immune system against new viral attacks

New machine learning model predicts COVID-19 severity

Fetal and neonatal therapy combination may lessen the aftereffects of congenital CMV infection

SARS-CoV-2 is resistant to extreme variations in temperature, finds study

New covid cases plunge 25% or more as behavior changes

Common anticoagulant drug could be repurposed to help alleviate Covid-19 infections

Moderna vaccine shows robust suppression of SARS-CoV-2 infection in animal model

Melatonin synthesized in the lungs acts as a barrier against SARS-CoV-2

Vaccines delivered via skin may offer better protection against respiratory diseases

New model could help clinicians to safely allow two patients to share a single ventilator

Study shows several peridomestic mammal species are potential spreaders of SARS-CoV-2

Bispecific antibody shows efficacy against new SARS-CoV-2 variants

Promising nanobodies against COVID-19 produced by llamas

Second-generation double antibody protects from SARS-CoV-2 and its tested variants

Does hypertension always lead to severe COVID-19?

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News